1167 related articles for article (PubMed ID: 17845407)
21. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].
Pacor ML; Biasi D; Maleknia T
Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis Part II. Evaluation of skin reactivity and concentration of serum antigen specific immunoglobulin E directed against selected airborne allergens].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(3-4):184-92. PubMed ID: 16119162
[TBL] [Abstract][Full Text] [Related]
23. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
24. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
[TBL] [Abstract][Full Text] [Related]
25. Distinctive immunoglobulin E anti-house dust allergen-binding specificities in a tropical Australian Aboriginal community.
Hales BJ; Laing IA; Pearce LJ; Hazell LA; Mills KL; Chua KY; Thornton RB; Richmond P; Musk AW; James AL; Lesouëf PN; Thomas WR
Clin Exp Allergy; 2007 Sep; 37(9):1357-63. PubMed ID: 17845417
[TBL] [Abstract][Full Text] [Related]
26. Epicutaneous sensitization with Dermatophagoides farinae induces generalized allergic dermatitis and elevated mite-specific immunoglobulin E levels in a canine model of atopic dermatitis.
Pucheu-Haston CM; Jackson HA; Olivry T; Dunston SM; Hammerberg B
Clin Exp Allergy; 2008 Apr; 38(4):667-79. PubMed ID: 18307530
[TBL] [Abstract][Full Text] [Related]
27. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
28. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Marsella R
Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
[TBL] [Abstract][Full Text] [Related]
29. [Results of desensitization using household dust mite in patients with atopic dermatitis].
Samochocki Z; Rudzki E
Przegl Dermatol; 1990; 77(2):132-6. PubMed ID: 2217840
[TBL] [Abstract][Full Text] [Related]
30. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
[TBL] [Abstract][Full Text] [Related]
31. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
O'Brien RM; Byron KA; Varigos GA; Thomas WR
Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
[TBL] [Abstract][Full Text] [Related]
32. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
[TBL] [Abstract][Full Text] [Related]
33. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
[TBL] [Abstract][Full Text] [Related]
34. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite.
Elazab SZ; Hessam WF; Gomaa AH
Egypt J Immunol; 2018 Jun; 25(2):97-106. PubMed ID: 30600952
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
[TBL] [Abstract][Full Text] [Related]
36. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.
Novak N; Bieber T; Hoffmann M; Fölster-Holst R; Homey B; Werfel T; Sager A; Zuberbier T
J Allergy Clin Immunol; 2012 Oct; 130(4):925-31.e4. PubMed ID: 22947344
[TBL] [Abstract][Full Text] [Related]
38. Atopic dermatitis in young children is associated with impaired interleukin-10 and interferon-gamma responses to allergens, vaccines and colonizing skin and gut bacteria.
Dunstan JA; Hale J; Breckler L; Lehmann H; Weston S; Richmond P; Prescott SL
Clin Exp Allergy; 2005 Oct; 35(10):1309-17. PubMed ID: 16238790
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
